Safety and immunogenicity of a prototype oral whole-cell killed Campylobacter vaccine administered with a mucosal adjuvant in non-human primates

By Baqar S.   Bourgeois A.L.   Schultheiss P.J.   Walker R.I.   Rollins D.M.   Haberberger R.L.   Pavlovskis O.R.  

Vaccine, Vol. 13, Iss. 1, 1995-01 ,pp. : 22-28

Elsevier

Access to resources Recommend Favorite

Safety and immunogenicity of a heptavalent pneumococcal conjugate vaccine in infants

By Zangwill K.M.   Greenberg D.P.   Chiu C.-Y.   Mendelman P.   Wong V.K.   Chang S.-J.   Partridge S.   Ward J.I.  

Vaccine, Vol. 21, Iss. 17, 2003-05 ,pp. : 1894-1900

Elsevier

Access to resources Recommend Favorite

Human therapeutic cocaine vaccine: safety and immunogenicity

By Kosten T.R.   Rosen M.   Bond J.   Settles M.   Roberts J.S.C.   Shields J.   Jack L.   Fox B.  

Vaccine, Vol. 20, Iss. 7, 2002-01 ,pp. : 1196-1204

Elsevier

Access to resources Recommend Favorite

Safety and immunogenicity of a new formulation of an inactivated hepatitis A vaccine

By Dagan R.   Greenberg D.   Goldenbertg-Gehtman P.   Vidor E.   Briantais P.   Pinsk V.   Athias O.   Dumas R.  

Vaccine, Vol. 17, Iss. 15, 1999-04 ,pp. : 1919-1925

Elsevier

Access to resources Recommend Favorite

An acellular pertussis vaccine in healthy adults: safety and immunogenicity

By Rothstein E.P.   Anderson E.L.   Decker M.D.   Poland G.A.   Reisinger K.S.   Blatter M.M.   Jacobson R.M.   Mink C.M.   Gennevois D.   Izu A.E.   Sinangil F.   Langenberg A.G.M.  

Vaccine, Vol. 17, Iss. 23, 1999-08 ,pp. : 2999-3006

Elsevier

Access to resources Recommend Favorite